Rising cancer costs could lead to global crisis

By Admin
A report published in the Lancet Oncology journal has claimed the developed world is “heading towards a crisis”, caused by the mounting cos...

A report published in the Lancet Oncology journal has claimed the developed world is “heading towards a crisis”, caused by the mounting cost of cancer care and treatment.

Estimations put the worldwide cost of cancer in 2008 at US$895 billion, while other figures suggest new cancer cases cost around $286 billion a year.

Within the report, 37 cancer experts from across the globe said cancer is becoming a huge economic and financial burden particularly in developed countries, as it is thought between four and seven percent of the yearly healthcare budget in these countries is spent on treating and caring for cancer patients.

To read the latest edition of Healthcare Global, click here

The researchers also warned the financial strain is likely to get more severe, as the volume of new cases of cancer in still increasing.

By 2030, the number of new incidences of the disease on an annual level is expected to reach 27 million, compared to just 12 million today.

“We are at a crossroads for affordable cancer care, where our choices – or refusal to make choices – will affect the lives of millions of people,” said Professor Richard Sullivan, the lead author.

“Do we bury our heads in the sand, keep our fingers crossed, and hope that it turns out fine, or do we have difficult debates and make hard choices within a socially responsible, cost-effective, and sustainable framework?”

He adds: “The consensus from all those involved is that policy makers, politicians, patients, and health care professionals need to address this issue now.

“We believe that value and affordable cancer care can be introduced into the cancer policy lexicon without detracting from quality, and that the management tools, evidence, and methods are available to affect this transformation across all developed countries.

Our magazine is now available on the iPad. Click here to download it.

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare